1. Home
  2. FA vs ARDX Comparison

FA vs ARDX Comparison

Compare FA & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Advantage Corporation

FA

First Advantage Corporation

HOLD

Current Price

$11.75

Market Cap

1.7B

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.65

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FA
ARDX
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
FA
ARDX
Price
$11.75
$6.65
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$19.00
$14.67
AVG Volume (30 Days)
1.2M
3.8M
Earning Date
06-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$860,205,000.00
$2,607,000.00
Revenue This Year
$85.19
$35.64
Revenue Next Year
$4.90
$34.12
P/E Ratio
N/A
N/A
Revenue Growth
12.63
N/A
52 Week Low
$8.82
$3.50
52 Week High
$19.01
$8.40

Technical Indicators

Market Signals
Indicator
FA
ARDX
Relative Strength Index (RSI) 51.85 46.75
Support Level N/A $5.47
Resistance Level $14.56 $6.69
Average True Range (ATR) 0.76 0.35
MACD 0.09 -0.10
Stochastic Oscillator 77.28 58.24

Price Performance

Historical Comparison
FA
ARDX

About FA First Advantage Corporation

First Advantage Corp is a provider of global software and data in the Human Resources technology industry. The company leverages proprietary technology and AI across its platforms, data, and APIs to deliver comprehensive background screening, digital identity, and verification solutions driven by innovation, automation, and customer success. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment. The group serves customers in over 200 countries and territories, modernising hiring and onboarding on a global scale.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: